With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles based startup Gallant is now opening its doors for the first time.

The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing his own pet’s struggle with debilitating illness and knowing firsthand that regenerative medicine and stem cell therapies could help.

“I struggled with debilitating chronic back pain for more than a decade, leaving me incapable of doing activities I loved, until regenerative medicine successfully cured my condition,” said Hirschhorn, in a statement. “At the same time, I watched my dog Rocky suffer from arthritis so painful that she couldn’t walk. I knew there had to be

Read More At Article Source | Article Attribution